BioCardia, Inc.
BCDA
$0.84
-$0.04-4.91%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 9.49% | 20.51% | |||
| Gross Profit | -9.49% | -20.51% | |||
| SG&A Expenses | 16.50% | 60.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.57% | 35.28% | |||
| Operating Income | -12.57% | -35.28% | |||
| Income Before Tax | -13.86% | -33.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.86% | -33.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.86% | -33.78% | |||
| EBIT | -12.57% | -35.28% | |||
| EBITDA | -12.59% | -35.44% | |||
| EPS Basic | -12.43% | 21.34% | |||
| Normalized Basic EPS | -12.49% | 21.34% | |||
| EPS Diluted | -12.43% | 21.34% | |||
| Normalized Diluted EPS | -12.49% | 21.34% | |||
| Average Basic Shares Outstanding | 1.27% | 70.07% | |||
| Average Diluted Shares Outstanding | 1.27% | 70.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||